PATENT CLAIM ANALYSIS

Application Number: 15976808
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "400000"]

Abstract:
Pharmaceutical compositions and single unit dosage forms of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione, or a pharmaceutically acceptable stereoisomer, prodrug, salt, solvate, hydrate, or clathrate, are provided herein. Also provided are methods of treating, managing, or preventing various disorders, such as cancer or an inflammatory disease.

Claim (Index 69):
The oral dosage form of  claim 68 , wherein the lubricant is sodium stearyl fumarate.

Metadata:
- Claim Count in Document: 170.0
- Percentile: 93.0
- Lexical Diversity: 1.39024
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14998262', '12783390', '11384381', '14508719', '10608077']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7668172483045332
- 35 USC 102 Novelty (BERT): 0.5394029151935906
- Combined Prediction Score: 0.744075814993439
- Mean Citation Score: 325.040406
- Max Citation Score: 376.8725
- Similarity Product: 267.82797897070645

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test